- Published on
Emergency And Acute Medicine – Cirrhosis
Overview And Pathophysiology
Cirrhosis is a progressive and chronic disease marked by ongoing inflammation, hepatocellular injury and necrosis, diffuse fibrosis, and the formation of regenerative nodules. These changes lead to distortion and eventual loss of normal hepatic lobular and vascular architecture. In advanced stages, cirrhosis is irreversible and results in intrahepatic portal hypertension due to increased sinusoidal resistance, compression of central veins, and abnormal arterial–portal venous shunting. Cirrhosis is a major public health concern and is among the leading causes of death in the United States.
Etiology And Risk Factors
Chronic alcohol abuse is the most common cause of cirrhosis in the United States, followed by chronic viral hepatitis B and C. Other causes include autoimmune hepatitis, primary biliary cirrhosis, secondary biliary cirrhosis from sclerosing cholangitis, and metabolic disorders such as hereditary hemochromatosis, Wilson disease, and porphyria. Drug-induced liver injury from agents such as acetaminophen, methotrexate, amiodarone, and methyldopa may contribute. Hepatic congestion from right-sided heart failure, constrictive pericarditis, or Budd–Chiari syndrome can lead to cirrhosis. Infiltrative diseases, nonalcoholic steatohepatitis, diffuse hepatocellular carcinoma, and chronic infections such as schistosomiasis or tertiary syphilis are less common causes. Pediatric causes include congenital biliary disorders, metabolic diseases, cystic fibrosis, and α1-antitrypsin deficiency.
Clinical Presentation
Cirrhosis may remain asymptomatic for years or present insidiously with nonspecific complaints such as fatigue, malaise, anorexia, nausea, weight loss, pruritus, and jaundice. Physical findings may include hepatomegaly, splenomegaly, abdominal discomfort, collateral venous circulation with caput medusae, palmar erythema, spider telangiectasias, parotid enlargement, clubbing, and nail changes. Endocrine manifestations include gynecomastia, testicular atrophy, impotence, amenorrhea, and loss of libido. Advanced disease may present with hypotension, fever, fetor hepaticus, asterixis, renal dysfunction, and signs of portal hypertension.
Complications And Decompensated Disease
The development of complications defines decompensated cirrhosis. These include ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, and variceal hemorrhage. Hepatic encephalopathy may be precipitated by gastrointestinal bleeding, infection, excessive dietary protein, electrolyte abnormalities, sedatives, constipation, or renal failure. Variceal bleeding occurs in approximately one-third of patients and carries a high mortality rate with each episode. Other complications include portal hypertensive gastropathy, hepatorenal syndrome due to reduced renal perfusion, and hepatopulmonary syndrome characterized by intrapulmonary vascular dilation and hypoxemia.
Diagnostic Evaluation
Diagnosis relies on a thorough history and physical examination supported by laboratory and imaging studies. Laboratory findings may include anemia, macrocytosis, leukopenia, thrombocytopenia, hypoalbuminemia, hyperbilirubinemia, prolonged prothrombin time, and elevated globulins. Transaminase levels reflect ongoing injury, with an AST to ALT ratio greater than two suggesting alcoholic liver disease. Additional testing is directed at identifying the underlying cause and complications, including viral hepatitis serologies, autoimmune markers, iron studies, ceruloplasmin, α1-antitrypsin levels, and α-fetoprotein. Ultrasound is used to assess liver architecture, ascites, splenomegaly, and portal vein patency, while CT imaging further evaluates abnormal findings. Endoscopy is indicated for variceal surveillance or upper gastrointestinal bleeding, and paracentesis is essential for new or worsening ascites or suspected spontaneous bacterial peritonitis.
Emergency And Acute Management
Initial management focuses on stabilizing the patient and treating life-threatening complications. Altered mental status should prompt administration of dextrose, thiamine, and naloxone as indicated. Hypotension should be corrected with intravenous fluids to prevent ischemic liver injury. Suspected variceal bleeding requires proton pump inhibitors, octreotide infusion, correction of coagulopathy, and urgent endoscopic intervention. Broad-spectrum antibiotics are indicated for suspected sepsis or spontaneous bacterial peritonitis. Hepatic encephalopathy is treated with lactulose and correction of precipitating factors. Ascites management includes sodium restriction, diuretics, and therapeutic paracentesis when necessary.
Definitive And Specialized Therapy
Treatment of underlying etiologies includes phlebotomy or chelation for hemochromatosis, immunosuppressive therapy for autoimmune hepatitis, antiviral therapy for chronic viral hepatitis when appropriate, ursodeoxycholic acid for primary biliary cirrhosis, and chelation therapy for Wilson disease. Nonselective β-blockers reduce the risk of variceal bleeding. Nutritional support with adequate calories and protein is essential unless limited by encephalopathy. Liver transplantation remains the only curative option for advanced cirrhosis.
Disposition And Follow-Up
Patients with acute decompensation, gastrointestinal bleeding, sepsis, advanced hepatic encephalopathy, hepatorenal syndrome, or hepatopulmonary syndrome require hospital admission, often to an intensive care unit. Patients with compensated cirrhosis and no acute complications may be managed as outpatients with close gastroenterology follow-up. All newly diagnosed patients should be referred for specialist evaluation and long-term management.
Clinical Pearls And Pitfalls
Cirrhosis presents with a wide range of clinical manifestations, and prognosis varies significantly depending on disease severity and complications. Any complication signals transition to decompensated disease and worsens prognosis. Symptoms of spontaneous bacterial peritonitis may be subtle, requiring a low threshold for diagnostic paracentesis. Early recognition and aggressive management of complications are critical to improving outcomes.
Overview And Pathophysiology
Cirrhosis is a progressive and chronic disease marked by ongoing inflammation, hepatocellular injury and necrosis, diffuse fibrosis, and the formation of regenerative nodules. These changes lead to distortion and eventual loss of normal hepatic lobular and vascular architecture. In advanced stages, cirrhosis is irreversible and results in intrahepatic portal hypertension due to increased sinusoidal resistance, compression of central veins, and abnormal arterial–portal venous shunting. Cirrhosis is a major public health concern and is among the leading causes of death in the United States.
Etiology And Risk Factors
Chronic alcohol abuse is the most common cause of cirrhosis in the United States, followed by chronic viral hepatitis B and C. Other causes include autoimmune hepatitis, primary biliary cirrhosis, secondary biliary cirrhosis from sclerosing cholangitis, and metabolic disorders such as hereditary hemochromatosis, Wilson disease, and porphyria. Drug-induced liver injury from agents such as acetaminophen, methotrexate, amiodarone, and methyldopa may contribute. Hepatic congestion from right-sided heart failure, constrictive pericarditis, or Budd–Chiari syndrome can lead to cirrhosis. Infiltrative diseases, nonalcoholic steatohepatitis, diffuse hepatocellular carcinoma, and chronic infections such as schistosomiasis or tertiary syphilis are less common causes. Pediatric causes include congenital biliary disorders, metabolic diseases, cystic fibrosis, and α1-antitrypsin deficiency.
Clinical Presentation
Cirrhosis may remain asymptomatic for years or present insidiously with nonspecific complaints such as fatigue, malaise, anorexia, nausea, weight loss, pruritus, and jaundice. Physical findings may include hepatomegaly, splenomegaly, abdominal discomfort, collateral venous circulation with caput medusae, palmar erythema, spider telangiectasias, parotid enlargement, clubbing, and nail changes. Endocrine manifestations include gynecomastia, testicular atrophy, impotence, amenorrhea, and loss of libido. Advanced disease may present with hypotension, fever, fetor hepaticus, asterixis, renal dysfunction, and signs of portal hypertension.
Complications And Decompensated Disease
The development of complications defines decompensated cirrhosis. These include ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, and variceal hemorrhage. Hepatic encephalopathy may be precipitated by gastrointestinal bleeding, infection, excessive dietary protein, electrolyte abnormalities, sedatives, constipation, or renal failure. Variceal bleeding occurs in approximately one-third of patients and carries a high mortality rate with each episode. Other complications include portal hypertensive gastropathy, hepatorenal syndrome due to reduced renal perfusion, and hepatopulmonary syndrome characterized by intrapulmonary vascular dilation and hypoxemia.
Diagnostic Evaluation
Diagnosis relies on a thorough history and physical examination supported by laboratory and imaging studies. Laboratory findings may include anemia, macrocytosis, leukopenia, thrombocytopenia, hypoalbuminemia, hyperbilirubinemia, prolonged prothrombin time, and elevated globulins. Transaminase levels reflect ongoing injury, with an AST to ALT ratio greater than two suggesting alcoholic liver disease. Additional testing is directed at identifying the underlying cause and complications, including viral hepatitis serologies, autoimmune markers, iron studies, ceruloplasmin, α1-antitrypsin levels, and α-fetoprotein. Ultrasound is used to assess liver architecture, ascites, splenomegaly, and portal vein patency, while CT imaging further evaluates abnormal findings. Endoscopy is indicated for variceal surveillance or upper gastrointestinal bleeding, and paracentesis is essential for new or worsening ascites or suspected spontaneous bacterial peritonitis.
Emergency And Acute Management
Initial management focuses on stabilizing the patient and treating life-threatening complications. Altered mental status should prompt administration of dextrose, thiamine, and naloxone as indicated. Hypotension should be corrected with intravenous fluids to prevent ischemic liver injury. Suspected variceal bleeding requires proton pump inhibitors, octreotide infusion, correction of coagulopathy, and urgent endoscopic intervention. Broad-spectrum antibiotics are indicated for suspected sepsis or spontaneous bacterial peritonitis. Hepatic encephalopathy is treated with lactulose and correction of precipitating factors. Ascites management includes sodium restriction, diuretics, and therapeutic paracentesis when necessary.
Definitive And Specialized Therapy
Treatment of underlying etiologies includes phlebotomy or chelation for hemochromatosis, immunosuppressive therapy for autoimmune hepatitis, antiviral therapy for chronic viral hepatitis when appropriate, ursodeoxycholic acid for primary biliary cirrhosis, and chelation therapy for Wilson disease. Nonselective β-blockers reduce the risk of variceal bleeding. Nutritional support with adequate calories and protein is essential unless limited by encephalopathy. Liver transplantation remains the only curative option for advanced cirrhosis.
Disposition And Follow-Up
Patients with acute decompensation, gastrointestinal bleeding, sepsis, advanced hepatic encephalopathy, hepatorenal syndrome, or hepatopulmonary syndrome require hospital admission, often to an intensive care unit. Patients with compensated cirrhosis and no acute complications may be managed as outpatients with close gastroenterology follow-up. All newly diagnosed patients should be referred for specialist evaluation and long-term management.
Clinical Pearls And Pitfalls
Cirrhosis presents with a wide range of clinical manifestations, and prognosis varies significantly depending on disease severity and complications. Any complication signals transition to decompensated disease and worsens prognosis. Symptoms of spontaneous bacterial peritonitis may be subtle, requiring a low threshold for diagnostic paracentesis. Early recognition and aggressive management of complications are critical to improving outcomes.
0 Comments
